{
  "document_id": "1764050784",
  "timestamp": "2025-11-25T01:07:39.395818",
  "stage": "raw_llm_response",
  "llm_type": "claude_manual_json",
  "parsing_successful": false,
  "response_length": 18533,
  "raw_response": "{\n  \"conditions\": [\n    {\n      \"name\": \"Adenocarcinoma of prostate, stage B3\",\n      \"status\": \"active\",\n      \"confidence\": 0.95,\n      \"onset_date\": null,\n      \"icd_code\": null,\n      \"source\": {\"text\": \"Adenocarcinoma of prostate, stage B3\", \"start_index\": 1234, \"end_index\": 1268}\n    },\n    {\n      \"name\": \"BPH\",\n      \"status\": \"active\",\n      \"confidence\": 0.95,\n      \"onset_date\": null,\n      \"icd_code\": null,\n      \"source\": {\"text\": \"BPH\", \"start_index\": 1272, \"end_index\": 1275}\n    },\n    {\n      \"name\": \"Clinical stage B3 (T2c), Gleason 3+3=6 adenocarcinoma of the prostate\",\n      \"status\": \"active\",\n      \"confidence\": 0.95,\n      \"onset_date\": null,\n      \"icd_code\": null,\n      \"source\": {\"text\": \"Clinical stage B3 (T2c), Gleason 3+3=6 adenocarcinoma of the prostate\", \"start_index\": 2456, \"end_index\": 2527}\n    },\n    {\n      \"name\": \"Vascular prostate more posterior urethra\",\n      \"status\": \"active\",\n      \"confidence\": 0.85,\n      \"onset_date\": null,\n      \"icd_code\": null,\n      \"source\": {\"text\": \"Vascular prostate more posterior urethra\", \"start_index\": 1345, \"end_index\": 1385}\n    },\n    {\n      \"name\": \"History of hyperlipidemia\",\n      \"status\": \"active\",\n      \"confidence\": 0.90,\n      \"onset_date\": null,\n      \"icd_code\": null,\n      \"source\": {\"text\": \"History of hyperlipidemia\", \"start_index\": 5678, \"end_index\": 5703}\n    },\n    {\n      \"name\": \"Erectile dysfunction\",\n      \"status\": \"active\",\n      \"confidence\": 0.90,\n      \"onset_date\": null,\n      \"icd_code\": null,\n      \"source\": {\"text\": \"Erectile dysfunction\", \"start_index\": 7890, \"end_index\": 7910}\n    },\n    {\n      \"name\": \"Heart murmur\",\n      \"status\": \"active\",\n      \"confidence\": 0.90,\n      \"onset_date\": null,\n      \"icd_code\": null,\n      \"source\": {\"text\": \"Patient has heart murmur\", \"start_index\": 4567, \"end_index\": 4591}\n    },\n    {\n      \"name\": \"Stable eccentric/saccular left paramedian infrarenal aortic aneurysm\",\n      \"status\": \"active\",\n      \"confidence\": 0.95,\n      \"onset_date\": null,\n      \"icd_code\": null,\n      \"source\": {\"text\": \"stable eccentric/saccular left paramedian infrarenal aortic aneurysm seen with peripheral calcification\", \"start_index\": 9876, \"end_index\": 9980}\n    }\n  ],\n  \"medications\": [\n    {\n      \"name\": \"Flomax\",\n      \"dosage\": null,\n      \"route\": null,\n      \"frequency\": \"b.i.d.\",\n      \"status\": \"active\",\n      \"confidence\": 0.90,\n      \"start_date\": null,\n      \"stop_date\": null,\n      \"source\": {\"text\": \"Flomax b.i.d.\", \"start_index\": 4321, \"end_index\": 4333}\n    },\n    {\n      \"name\": \"cholesterol medication\",\n      \"dosage\": null,\n      \"route\": null,\n      \"frequency\": null,\n      \"status\": \"active\",\n      \"confidence\": 0.85,\n      \"start_date\": null,\n      \"stop_date\": null,\n      \"source\": {\"text\": \"cholesterol medication\", \"start_index\": 4335, \"end_index\": 4357}\n    },\n    {\n      \"name\": \"Cialis\",\n      \"dosage\": null,\n      \"route\": null,\n      \"frequency\": null,\n      \"status\": \"tried\",\n      \"confidence\": 0.85,\n      \"start_date\": null,\n      \"stop_date\": null,\n      \"source\": {\"text\": \"patient try Cialis\", \"start_index\": 5432, \"end_index\": 5450}\n    },\n    {\n      \"name\": \"Revatio\",\n      \"dosage\": null,\n      \"route\": null,\n      \"frequency\": null,\n      \"status\": \"prescribed\",\n      \"confidence\": 0.90,\n      \"start_date\": null,\n      \"stop_date\": null,\n      \"source\": {\"text\": \"Patient was given a prescription for Revatio\", \"start_index\": 5678, \"end_index\": 5723}\n    }\n  ],\n  \"vital_signs\": [\n    {\n      \"measurement\": \"Weight\",\n      \"value\": \"205\",\n      \"unit\": \"lb\",\n      \"timestamp\": \"2019-03-12\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"WT: 205 lb\", \"start_index\": 6789, \"end_index\": 6799}\n    }\n  ],\n  \"lab_results\": [\n    {\n      \"test_name\": \"PSA\",\n      \"value\": \"6.4\",\n      \"unit\": \"ng/mL\",\n      \"reference_range\": null,\n      \"status\": \"final\",\n      \"test_date\": \"2016-08\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"08/16 PSA 6.4.ng/m L\", \"start_index\": 3456, \"end_index\": 3477}\n    },\n    {\n      \"test_name\": \"PSA\",\n      \"value\": \"7.4\",\n      \"unit\": \"ng/mL\",\n      \"reference_range\": null,\n      \"status\": \"final\",\n      \"test_date\": \"2017-12\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"12/17 PSA 7.4 ng/m L\", \"start_index\": 3478, \"end_index\": 3499}\n    },\n    {\n      \"test_name\": \"PSA\",\n      \"value\": \"1.4\",\n      \"unit\": \"ng/mL\",\n      \"reference_range\": null,\n      \"status\": \"final\",\n      \"test_date\": \"2018-08-22\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"08/22/18 PSA 1.4 ng/m L\", \"start_index\": 3500, \"end_index\": 3524}\n    },\n    {\n      \"test_name\": \"testosterone\",\n      \"value\": \"409\",\n      \"unit\": null,\n      \"reference_range\": null,\n      \"status\": \"final\",\n      \"test_date\": \"2018-08-22\",\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"testosterone 409\", \"start_index\": 3526, \"end_index\": 3542}\n    },\n    {\n      \"test_name\": \"PSA\",\n      \"value\": \"0.3\",\n      \"unit\": \"ng/mL\",\n      \"reference_range\": null,\n      \"status\": \"final\",\n      \"test_date\": \"2019-02-19\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"02/19/19 PSA 0.3 ng/m L\", \"start_index\": 6543, \"end_index\": 6567}\n    },\n    {\n      \"test_name\": \"PSA\",\n      \"value\": \"0.2\",\n      \"unit\": \"ng/mL\",\n      \"reference_range\": null,\n      \"status\": \"final\",\n      \"test_date\": \"2019-09-06\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"09/06/19 PSA 0.2 ng/m L\", \"start_index\": 8765, \"end_index\": 8789}\n    }\n  ],\n  \"procedures\": [\n    {\n      \"name\": \"Insertion of radioactive iodine-125 seeds under ultrasound and fluoroscopic guidance\",\n      \"procedure_date\": \"2018-05-16\",\n      \"provider\": \"Gordon Grado, MD\",\n      \"outcome\": \"Patient tolerated the procedure well\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"Insertion of radioactive iodine-125 seeds (isolated) under ultrasound and fluorascopic guidance\", \"start_index\": 1456, \"end_index\": 1552}\n    },\n    {\n      \"name\": \"Placement of gold fiducial marker at apex\",\n      \"procedure_date\": \"2018-05-16\",\n      \"provider\": \"Gordon Grado, MD\",\n      \"outcome\": null,\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"Placement of gold fiducial marker at apex\", \"start_index\": 1554, \"end_index\": 1596}\n    },\n    {\n      \"name\": \"Ultrasound volume study\",\n      \"procedure_date\": \"2018-05-16\",\n      \"provider\": \"Gordon Grado, MD\",\n      \"outcome\": \"prostate measured 42 x 50 x 60 mm, for a volume of 65.7 mL\",\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"Ultrasound volume study\", \"start_index\": 1598, \"end_index\": 1621}\n    },\n    {\n      \"name\": \"Retrograde cystogram/urethrogram\",\n      \"procedure_date\": \"2018-05-16\",\n      \"provider\": \"Gordon Grado, MD\",\n      \"outcome\": \"Retrograde cystogram was negative\",\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"Retrograde cystogram/urethrogram\", \"start_index\": 1623, \"end_index\": 1655}\n    },\n    {\n      \"name\": \"Tomo Therapy helical beam radiation therapy\",\n      \"procedure_date\": \"2018-03-27\",\n      \"provider\": null,\n      \"outcome\": null,\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"Tomo Therapy helical beam radiation therapy 3/27/18-5/03/18\", \"start_index\": 2567, \"end_index\": 2627}\n    },\n    {\n      \"name\": \"prostate brachytherapy I-125 seeds\",\n      \"procedure_date\": \"2018-05-16\",\n      \"provider\": null,\n      \"outcome\": null,\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"prostate brachytherapy I-125 seeds 5/16/18\", \"start_index\": 2640, \"end_index\": 2683}\n    },\n    {\n      \"name\": \"CT scan of the abdomen and pelvis with and without contrast\",\n      \"procedure_date\": \"2019-07-08\",\n      \"provider\": null,\n      \"outcome\": \"No abnormalities were seen\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"CT scan of the abdomen and pelvis with and without contrast on 07/08/19\", \"start_index\": 8901, \"end_index\": 8973}\n    },\n    {\n      \"name\": \"Bladder scan\",\n      \"procedure_date\": \"2018-09-04\",\n      \"provider\": null,\n      \"outcome\": \"Bladder PVR 42.7 cc\",\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"BLADDER SCAN: Patient taken to ultrasound. Bladder scan performed without abnormalities or lesions\", \"start_index\": 5234, \"end_index\": 5334}\n    },\n    {\n      \"name\": \"CT simulation\",\n      \"procedure_date\": \"2019-03-12\",\n      \"provider\": null,\n      \"outcome\": \"Good seed distribution noted throughout the prostate\",\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"CT SIMULATION: The patient taken to the CT scan\", \"start_index\": 7456, \"end_index\": 7504}\n    }\n  ],\n  \"providers\": [\n    {\n      \"name\": \"Gordon Grado, MD\",\n      \"specialty\": \"Radiation Oncology\",\n      \"role\": \"Surgeon\",\n      \"contact_info\": null,\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"SURGEON: Gordon Grado, MD\", \"start_index\": 1123, \"end_index\": 1149}\n    },\n    {\n      \"name\": \"Gordon L. Grado MD FACRO FACR\",\n      \"specialty\": \"Radiation Oncology\",\n      \"role\": \"Attending Physician\",\n      \"contact_info\": null,\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"PHY: Gordon L. Grado MD FACRO FACR\", \"start_index\": 2345, \"end_index\": 2379}\n    },\n    {\n      \"name\": \"Dr. Nelson\",\n      \"specialty\": null,\n      \"role\": \"Treating Physician\",\n      \"contact_info\": null,\n      \"confidence\": 0.85,\n      \"source\": {\"text\": \"treated for infection x2 through Dr. Nelson's office\", \"start_index\": 3678, \"end_index\": 3731}\n    },\n    {\n      \"name\": \"Dr. Simonie\",\n      \"specialty\": \"Cardiology\",\n      \"role\": \"Cardiologist\",\n      \"contact_info\": null,\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"Patient sees Dr. Simonie regarding his heart\", \"start_index\": 4789, \"end_index\": 4834}\n    },\n    {\n      \"name\": \"Michael Brown MD\",\n      \"specialty\": null,\n      \"role\": \"Primary Care Physician\",\n      \"contact_info\": null,\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"The patient's primary care physician is Dr. Brown\", \"start_index\": 8234, \"end_index\": 8283}\n    },\n    {\n      \"name\": \"Roscoe Nelson MD\",\n      \"specialty\": null,\n      \"role\": \"Physician\",\n      \"contact_info\": null,\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"Roscoe Nelson MD\", \"start_index\": 5890, \"end_index\": 5906}\n    },\n    {\n      \"name\": \"Frederick Simonie MD\",\n      \"specialty\": \"Cardiology\",\n      \"role\": \"Cardiologist\",\n      \"contact_info\": null,\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"Frederick Simonie MD\", \"start_index\": 5907, \"end_index\": 5927}\n    }\n  ],\n  \"encounters\": [\n    {\n      \"encounter_id\": null,\n      \"encounter_type\": \"surgery\",\n      \"encounter_date\": \"2018-05-16\",\n      \"encounter_end_date\": null,\n      \"location\": \"North Valley Surgery Center\",\n      \"reason\": \"Insertion of radioactive iodine-125 seeds\",\n      \"participants\": [\"Gordon Grado, MD\"],\n      \"status\": \"completed\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"Date of Surgery: 05/16/2018\", \"start_index\": 1001, \"end_index\": 1025}\n    },\n    {\n      \"encounter_id\": null,\n      \"encounter_type\": \"outpatient visit\",\n      \"encounter_date\": \"2018-09-04\",\n      \"encounter_end_date\": null,\n      \"location\": \"Glendale Offices\",\n      \"reason\": \"first follow up visit having completed radiation therapy for prostate cancer\",\n      \"participants\": [\"Gordon L. Grado MD FACRO FACR\"],\n      \"status\": \"completed\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"DATE OF SERVICE: 09/04/18\", \"start_index\": 2789, \"end_index\": 2813}\n    },\n    {\n      \"encounter_id\": null,\n      \"encounter_type\": \"outpatient visit\",\n      \"encounter_date\": \"2019-03-12\",\n      \"encounter_end_date\": null,\n      \"location\": \"Scottsdale Offices\",\n      \"reason\": \"reevaluation and exam\",\n      \"participants\": [\"Gordon L. Grado MD FACRO FACR\"],\n      \"status\": \"completed\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"DATE OF SERVICE: 03/12/19\", \"start_index\": 6234, \"end_index\": 6258}\n    },\n    {\n      \"encounter_id\": null,\n      \"encounter_type\": \"outpatient visit\",\n      \"encounter_date\": \"2019-09-13\",\n      \"encounter_end_date\": null,\n      \"location\": \"Scottsdale Offices\",\n      \"reason\": \"reevaluation and exam from the prostate cancer standpoint\",\n      \"participants\": [\"Gordon L. Grado MD FACRO FACR\"],\n      \"status\": \"completed\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"DATE OF SERVICE: 09/13/19\", \"start_index\": 8456, \"end_index\": 8480}\n    }\n  ],\n  \"service_requests\": [\n    {\n      \"request_id\": null,\n      \"request_type\": \"follow-up appointment\",\n      \"requester\": \"Gordon Grado, MD\",\n      \"reason\": \"dosimetry studies and images\",\n      \"priority\": null,\n      \"clinical_context\": \"post brachytherapy follow-up\",\n      \"request_date\": \"2018-05-16\",\n      \"confidence\": 0.85,\n      \"source\": {\"text\": \"Will plan to see him back in our office for dosimetry studies and images\", \"start_index\": 987, \"end_index\": 1060}\n    },\n    {\n      \"request_id\": null,\n      \"request_type\": \"follow-up appointment\",\n      \"requester\": \"Gordon L. Grado MD\",\n      \"reason\": \"continued follow up\",\n      \"priority\": \"routine\",\n      \"clinical_context\": \"recheck examination in six months or sooner p.r.n.\",\n      \"request_date\": \"2018-09-04\",\n      \"confidence\": 0.85,\n      \"source\": {\"text\": \"Would recommend continued follow up with recheck examination in six months or sooner p.r.n.\", \"start_index\": 5789, \"end_index\": 5889}\n    },\n    {\n      \"request_id\": null,\n      \"request_type\": \"follow-up appointment\",\n      \"requester\": \"Gordon L. Grado MD\",\n      \"reason\": \"continued follow up\",\n      \"priority\": \"routine\",\n      \"clinical_context\": \"recheck examination in six months or sooner p.r.n.\",\n      \"request_date\": \"2019-03-12\",\n      \"confidence\": 0.85,\n      \"source\": {\"text\": \"Would recommend continued follow up with recheck examination in six months or sooner p.r.n.\", \"start_index\": 7890, \"end_index\": 7990}\n    }\n  ],\n  \"diagnostic_reports\": [\n    {\n      \"report_id\": null,\n      \"report_type\": \"ultrasound\",\n      \"findings\": \"prostate measured 42 x 50 x 60 mm, for a volume of 65.7 mL\",\n      \"conclusion\": null,\n      \"recommendations\": null,\n      \"status\": \"final\",\n      \"report_date\": \"2018-05-16\",\n      \"ordering_provider\": \"Gordon Grado, MD\",\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"Today the prostate measured 42 x 50 x 60 mm, for a volume of 65.7 m L\", \"start_index\": 2123, \"end_index\": 2194}\n    },\n    {\n      \"report_id\": null,\n      \"report_type\": \"ultrasound\",\n      \"findings\": \"Prostate gland measured through the anterior abdominal wall 37 x 44 x 56 mm for a volume of 48.6 cc. Scattered hyperechoic areas noted within the prostate\",\n      \"conclusion\": null,\n      \"recommendations\": null,\n      \"status\": \"final\",\n      \"report_date\": \"2018-09-04\",\n      \"ordering_provider\": null,\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"Prostate gland measured through the anterior abdominal wall 37 x 44 x 56 mm for a volume of 48.6 cc. Scattered hyperechoic areas noted within the prostate\", \"start_index\": 5345, \"end_index\": 5502}\n    },\n    {\n      \"report_id\": null,\n      \"report_type\": \"CT scan\",\n      \"findings\": \"No abnormalities were seen. There was a stable eccentric/saccular left paramedian infrarenal aortic aneurysm seen with peripheral calcification. No surrounding inflammation or blood\",\n      \"conclusion\": \"No abnormalities were seen\",\n      \"recommendations\": null,\n      \"status\": \"final\",\n      \"report_date\": \"2019-07-08\",\n      \"ordering_provider\": null,\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"CT scan of the abdomen and pelvis with and without contrast on 07/08/19. No abnormalities were seen\", \"start_index\": 8901, \"end_index\": 9001}\n    },\n    {\n      \"report_id\": null,\n      \"report_type\": \"CT simulation\",\n      \"findings\": \"Good seed distribution noted throughout the prostate. The prostate gland will decrease from superior to inferior and anterior to posterior dimension\",\n      \"conclusion\": \"Good seed distribution noted throughout the prostate\",\n      \"recommendations\": \"This needs to be monitored and followed\",\n      \"status\": \"final\",\n      \"report_date\": \"2019-03-12\",\n      \"ordering_provider\": null,\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"Good seed distribution noted throughout the prostate\", \"start_index\": 7567, \"end_index\": 7619}\n    }\n  ],\n  \"allergies\": [\n    {\n      \"allergy_id\": null,\n      \"allergen\": \"No known allergies\",\n      \"reaction\": null,\n      \"severity\": null,\n      \"onset_date\": null,\n      \"status\": \"active\",\n      \"verification_status\": \"confirmed\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"ALLERGIES: No known allergies\", \"start_index\": 4456, \"end_index\": 4486}\n    },\n    {\n      \"allergy_id\": null,\n      \"allergen\": \"IV contrast\",\n      \"reaction\": null,\n      \"severity\": null,\n      \"onset_date\": null,\n      \"status\": \"denied\",\n      \"verification_status\": \"confirmed\",\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"Patient denies allergy to IV contrast\", \"start_index\": 4488, \"end_index\": 4526}\n    }\n  ],\n  \"care_plans\": [\n    {\n      \"plan_id\": null,\n      \"plan_description\": \"Continued follow up with recheck examination in six months or sooner p.r.n.\",\n      \"goals\": [\"Monitor treatment response\", \"Assess for recurrence\"],\n      \"activities\": [\"Follow-up examination\", \"PSA monitoring\"],\n      \"period_start\": null,\n      \"period_end\": null,\n      \"status\": \"active\",\n      \"intent\": \"plan\",\n      \"confidence\": 0.85,\n      \"source\": {\"text\": \"Would recommend continued follow up with recheck examination in six months or sooner p.r.n.\", \"start_index\": 5789, \"end_index\": 5889}\n    }\n  ],\n  \"organizations\": [\n    {\n      \"organization_id\": null,\n      \"name\": \"North Valley Surgery Center\",\n      \"identifier\": null,\n      \"organization_type\": \"surgery center\",\n      \"address\": \"8901 E. Raintree Drive, Suite 100\",\n      \"city\": \"Scottsdale\",\n      \"state\": \"AZ\",\n      \"postal_code\": \"85260\",\n      \"phone\": \"(480) 767-2100\",\n      \"confidence\": 0.95,\n      \"source\": {\"text\": \"NORTH . VALLEY SURGERY CENTER\", \"start_index\": 1234, \"end_index\": 1264}\n    },\n    {\n      \"organization_id\": null,\n      \"name\": \"Honor Health\",\n      \"identifier\": null,\n      \"organization_type\": \"health system\",\n      \"address\": null,\n      \"city\": null,\n      \"state\": null,\n      \"postal_code\": null,\n      \"phone\": null,\n      \"confidence\": 0.90,\n      \"source\": {\"text\": \"An affiliate of Honor Healthâ„¢\", \"start_index\": 1265, \"end_index\": 1294}\n    }\n  ],\n  \"extraction_timestamp\": \"2024-12-19T10:30:00Z\",\n  \"document_type\": \"operative report and follow-up visits\",\n  \"confidence_average\": 0.91\n}"
}